We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64.49 as of ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novo ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Swedish automotive company Volvo Cars Corp. notified Northvolt AB, a partner in the NOVO Energy joint venture, of its intention to use the pre-emptive share repurchase right to acquire full control ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Novo, which had earlier planned for a 2026 launch ... US regulators deny rehearing on co-located Amazon data center energy pact 8:58 PM UTC · Updated ago Energycategory Chevron's Venezuelan ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Douglas McIntyre, Editor-in-Chief at Climate Crisis 24/7, reports that the city of Ann Arbor, Michigan, is exploring the ...

Novo Nordisk has been on the hunt for differentiated ... a key role in a metabolic pathway regulating fat accumulation and energy balance. According to Lexicon, this molecule may also activate ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...